Quick Menu

Upcoming Journals

Annual Research & Review in Biology

Annual Research & Review in Biology, ISSN: 2347-565X,Vol.: 17, Issue.: 5

Review Article

Therapeutic Management of Benign Prostatic Hyperplasia: From Synthetics to Naturals


Ashish Kumar Jena1, Karan Vasisht1 and Maninder Karan1*

1University Institute of Pharmaceutical Sciences–UGC Centre of Advanced Study, Faculty of Pharmaceutical Sciences, Panjab University, Chandigarh-160014, India.


Article Information
(1) George Perry, Dean and Professor of Biology, University of Texas at San Antonio, USA.
(1) Fadi Dalati, CHU Saint Pierre, Belgium.
(2) Bum Soo Kim, Kyungpook National University, Korea.
Complete Peer review History: http://www.sciencedomain.org/review-history/21162




Benign prostatic hyperplasia (BPH) is a common urological disorder of men with multi-factorial etiology, particularly affecting the lifestyle of elderly patients. Sex steroid hormones essential for the development and growth of normal prostate are recognized as major risk factors, though many others such as aging, genetic, diet, hypertension, obesity, smoking, alcohol and physical activity have been identified as playing a significant role. Depending on the stage of BPH, and complications involved, the treatment includes different classes of synthetic drugs and/or surgery while some phytotherapeutic agents also represent the first line of treatment. Numerous plant extracts, fruits, and beverages are used alone or in combinations for the management of BPH with few having emerged as the choicest treatment. The public interest in natural agents is largely because of the side effects related to synthetics and a general fear of morbidity arising out of surgery. The phytotherapeutic agents represent the most promising and safe alternative as antiBPH agents signifying a strong area for further exploration by medicinal chemists. This review provides a complete insight on the epidemiology, pathophysiology, various risk factors involved, and different therapeutic approaches available. A brief outline of the surgical and synthetic treatment with detailed note on phytotherapeutics as the treatment options for the prevention and management of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS) is provided.


Keywords :

Enlarged prostate; BPH/LUTS; epidemiology; pathophysiology; risk factors; management, synthetics; surgery; phytotherapeutics.


Full Article - PDF    Page 1-34    Article Metrics


DOI : 10.9734/ARRB/2017/35896

Review History    Comments

Search this site

Advanced Search

Announcement & News

Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and its editors

We are happy to inform that Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and ...

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...


  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.